1. OUTCOMES OF TREATMENT FOR OBESE PATIENTS WITH ADVANCED HODGKIN LYMPHOMA IN THE RATHL TRIAL (CRUK/07/033). (June 2017) Authors: Preston, A.; Kirkwood, A.; Federico, M.; Trotman, J.; Fossa, A.; Stevens, L.; Clifton‐Hadley, L.; Patrick, P.; Berkahn, L.; d'Amore, F.; Enblad, G.; Luminari, S.; Radford, J.; Johnson, P.W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S203: ABSCOPAL EFFECT OF RADIOTHERAPY AND NIVOLUMAB IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: PRE-PLANNED INTERIM ANALYSIS OF THE INTERNATIONAL GHSG PHASE II AERN TRIAL. (23rd June 2022) Authors: Bröckelmann, P.; Bühnen, I.; Zijlstra, J.; Fossa, A.; Meissner, J.; Mathas, S.; Rosenbrock, J.; Kobe, C.; Fuchs, M.; Plütschow, A.; Marnitz, S.; Borchmann, P.; Engert, A.; Baues, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗